Primary Generalized Tonic-Clonic Seizures

Neurology·MeSH: Epilepsy

9 drugs in development·7 companies·1 clinical trial

Drug Pipeline by Phase

Approved(8)

Drug	Company
fycompa	CATALYST PHARMACEUTICALS, INC. (CPRX)
FYCOMPA®	CATALYST PHARMACEUTICALS, INC. (CPRX)
lamotrigine	Teva Pharmaceutical Industries Limited (TEVA)
levetiracetam	Mylan II B.V. (MYL)
levetiracetam in	NEXUS BIOPHARMA INC (NEXS)
topiramate	Teva Pharmaceutical Industries Limited (TEVA)
topiramate	DR REDDYS LABORATORIES LTD (RDY)
Trokendi XR	SUPERNUS PHARMACEUTICALS, INC. (SUPN)

Phase 3(1)

Drug	Company
xen1101	Xenon Pharmaceuticals Inc. (XENE)

BioSniper tracks 9 drugs in development for Primary Generalized Tonic-Clonic Seizures across 7 companies.

There are 1 clinical trial targeting Primary Generalized Tonic-Clonic Seizures tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.